全文获取类型
收费全文 | 20886篇 |
免费 | 1389篇 |
国内免费 | 420篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 512篇 |
妇产科学 | 537篇 |
基础医学 | 3225篇 |
口腔科学 | 449篇 |
临床医学 | 1724篇 |
内科学 | 2775篇 |
皮肤病学 | 280篇 |
神经病学 | 1351篇 |
特种医学 | 713篇 |
外国民族医学 | 4篇 |
外科学 | 1529篇 |
综合类 | 2415篇 |
现状与发展 | 2篇 |
预防医学 | 1234篇 |
眼科学 | 154篇 |
药学 | 2558篇 |
3篇 | |
中国医学 | 901篇 |
肿瘤学 | 2243篇 |
出版年
2023年 | 214篇 |
2022年 | 428篇 |
2021年 | 541篇 |
2020年 | 493篇 |
2019年 | 621篇 |
2018年 | 633篇 |
2017年 | 595篇 |
2016年 | 646篇 |
2015年 | 685篇 |
2014年 | 1197篇 |
2013年 | 1419篇 |
2012年 | 1081篇 |
2011年 | 1398篇 |
2010年 | 994篇 |
2009年 | 1039篇 |
2008年 | 964篇 |
2007年 | 1033篇 |
2006年 | 930篇 |
2005年 | 820篇 |
2004年 | 763篇 |
2003年 | 633篇 |
2002年 | 508篇 |
2001年 | 474篇 |
2000年 | 437篇 |
1999年 | 363篇 |
1998年 | 297篇 |
1997年 | 311篇 |
1996年 | 239篇 |
1995年 | 243篇 |
1994年 | 233篇 |
1993年 | 189篇 |
1992年 | 150篇 |
1991年 | 134篇 |
1990年 | 157篇 |
1989年 | 102篇 |
1988年 | 92篇 |
1987年 | 97篇 |
1986年 | 80篇 |
1985年 | 165篇 |
1984年 | 215篇 |
1983年 | 106篇 |
1982年 | 149篇 |
1981年 | 136篇 |
1980年 | 112篇 |
1979年 | 102篇 |
1978年 | 80篇 |
1976年 | 72篇 |
1975年 | 65篇 |
1974年 | 75篇 |
1973年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
EIJI TAKEDA HIRONORI YAMAMOTO YUTAKA TAKETANI KEN-ICHI MIYAMOTO 《Pediatrics international》1997,39(4):508-513
Two distinct hereditary defects, vitamin D-dependent rickets type I (VDDR I) and type II (VDDR II), have been recognized in vitamin D metabolism. VDDR I is suggested to be a deficiency of the renal 25-hydroxyvitamin D (25(OH)D)-1α-hydroxylase. Muscle weakness and rickets are the prominent clinical findings. A normal physiologic dose of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 is sufficient to maintain remission of rickets in this disorder. VDDR II consists of a spectrum of intracellular vitamin D receptor (VDR) defects and is characterized by the early onset of severe rickets and associated alopecia. This can be attributed to mutations in the VDR gene. Massive doses of vitamin D analogs and calcium supplementation is usually required for the treatment; however, the response to therapy is sometimes variable. 相似文献
72.
73.
Takashi Sekiguchi Makoto Noguchi Kenji Nakamori Gen-iku Kohama 《International journal of clinical oncology / Japan Society of Clinical Oncology》1997,2(1):21-28
Background Changes in interstitial collagen in human oral cancer have not yet been fully studied. We examined the relationship between
the degree of interstitial collagen deposition at the invading edge of the tumor, and the clinical and pathologic findings
in oral squamous cell carcinoma. We also investigated the therapeutic implication of the changes in distribution patterns
of collagen deposition by comparing biopsy specimens and surgical specimens.
Methods Immunohistochemical staining was performed by the streptavidin-biotin method using antibody against human type I collagen
for visualizing interstitial collagen in 50 biopsy and 45 surgical specimens.
Results Carcinomas with scanty interstitial collagen in biopsy specimens tended to have highly malignant characteristics. Large carcinomas
with scanty deposition both in biopsy and surgical specimens were likely to have positive resection margins in spite of radical
surgery.
Conclusion Immunostaining patterns for type I collagen of oral squamous cell carcinomas can provide information of importance in determining
safe resection margins. 相似文献
74.
Hikoyoshi Chin Hideo Matsui Akira Mitsuhashi Kohichi Nagao Souei Sekiya 《Gynecologic oncology》1998,71(3):469-475
Primary carcinoma of the fallopian tube is extremely rare and the preoperative diagnosis is often misdiagnosed as an ovarian carcinoma. We report a patient with primary carcinoma of the fallopian tube, strongly suspected preoperatively on the basis of characteristic clinical symptoms, elevated CA125 levels, and transvaginal sonography, computed tomography, and magnetic resonance imaging findings. The histology of fallopian tube carcinoma was demonstrated as transitional cell carcinoma. Extensive review of the literature showed that our case seemed to be the 14th case of primary transitional cell carcinoma of the fallopian tube. 相似文献
75.
Serum levels of C3 and Factors I and B in minimal change disease 总被引:2,自引:0,他引:2
Abstract Background: Relapses are an important problem in minimal change disease, which accounts for most of the cases of childhood nephrotic syndrome. Because of defects in the humoral immune system, patients are predisposed to infection in nephrotic syndrome and infection is the most important complication that determines mortality and morbidity.
Methods: In this study, serum levels of Factors I and B and C3 were studied to evaluate the relationships between nephrotic syndrome and infection in 17 children with nephrotic syndrome (24–96 months of age) and 10 healthy children (27–84 months of age).
Results: Serum levels of Factors I and B were found to be lowered in the active disease group compared with the control group. These values were lowest for the infection group. Although it was observed that these values increased with steroid treatment, they did not reach normal levels. The parameters in remission were not different from the parameters in the control subjects. The serum level of C3 was found to be high during the active disease state and returned to normal levels during remission.
Conclusions: The patients with active minimal change disease had infections such as peritonitis, septicemia and urinary tract infection because of low concentrations of Factors I and B in their sera. 相似文献
Methods: In this study, serum levels of Factors I and B and C3 were studied to evaluate the relationships between nephrotic syndrome and infection in 17 children with nephrotic syndrome (24–96 months of age) and 10 healthy children (27–84 months of age).
Results: Serum levels of Factors I and B were found to be lowered in the active disease group compared with the control group. These values were lowest for the infection group. Although it was observed that these values increased with steroid treatment, they did not reach normal levels. The parameters in remission were not different from the parameters in the control subjects. The serum level of C3 was found to be high during the active disease state and returned to normal levels during remission.
Conclusions: The patients with active minimal change disease had infections such as peritonitis, septicemia and urinary tract infection because of low concentrations of Factors I and B in their sera. 相似文献
76.
K. Mross B. Hauns B. Häring T. Bauknecht H. G. Meerpohl C. Unger H. Maier-Lenz 《Annals of oncology》1998,9(5):569-572
Background: Paclitaxel (PAC) is one of the major anti-cancer drugs,effective in different tumors. Studies with 24-hour infusion with 135mg/m2 and a three-hour infusion with 175 mg/m2showed a significant schedule-dependent toxicity. We evaluated a one-hourinfusion schedule within a phase I study to determine the dose limitingtoxicity (DLT), the maximum tolerated dose (MTD), and the anti-cancerefficacy.Patients and methods: Patients with advanced malignant tumors weretreated within cohorts by one-hour infusional paclitaxel starting with 150mg/m2 and stepwise escalation with 25 mg/m2increments. Therapy was repeated in three-week intervals. Cycles wererepeated until progression. Toxicity was closely monitored, anti-cancerefficacy was only evaluated in those patients who received at minimum twotreatment cycles.Results: Thirty-four patients entered the study (11 NSCLC, five SCLC,seven ovarian cancer, one cervix cancer, nine MBC, one HN cancer). The MTDwas PAC 250 mg/m2. The DLT was central and peripheralneuropathy (WHO grade 3). Other significant toxicities were fatigue,myalgia/arthralgia and paraesthesia. No significant myelotoxicity wasobserved. Totally twentyone patients were evaluable for response. A partialresponse was observed in five (24%) patients (two NSCLC, two ovariancancer, one head and neck cancer). Three (14%) patients had stabledisease and in 13 (62%) patients progressive disease was observed.Conclusions: Paclitaxel 225 mg/m2 on day 1 administered asone-hour infusion and repeated every three weeks can be given safely, featuredno relevant myelotoxicity, and is the recommended dose for phase II studies. 相似文献
77.
血清CA125、CA199对肝硬化和肝癌的诊断价值 总被引:14,自引:0,他引:14
CA125为分子量在200—1000KD的大分子糖蛋白,大量临床研究证实:CA125在卵巢癌的诊断、良恶性鉴别、复发预报、疗效监测以及预后判断等方面有效大的实用价值。CA199是Koprouski等1979年从人结肠癌细胞株中提取出来的一种糖蛋白.主要在胎儿的小肠黏膜杯状细胞、胰胆管上皮细胞及成人胰腺癌、胃癌、结肠癌时合成,主要用于胰腺癌的早期诊断, 相似文献
78.
目的 :探讨多种肿瘤标志物对卵巢癌的诊断价值。方法 :应用化学发光法测定卵巢肿瘤、子宫内膜异位症和盆腔炎性包块的CA1 2 5、CA1 99、CA1 5 3、AFP、CEA阳性率。结果 :卵巢癌患者中 ,80 .6 0 %CA1 2 5阳性 ,92 .5 3%联合检测阳性 ,阳性率明显高于良性肿瘤、子宫内膜异位症、盆腔炎性包块患者 (P <0 .0 1 ) ;CA1 2 5与卵巢癌的临床分期及病理类型无关 ,但Ⅰ期卵巢癌患者的血清CA1 2 5值明显低于Ⅱ~Ⅳ期患者 (P <0 .0 1 )。结论 :CA1 2 5对卵巢癌的诊断有一定的价值 ,联合监测能提高卵巢癌的诊断率 ,尤其对早期卵巢癌。 相似文献
79.
血清CA125结合B超对绝经后妇女卵巢恶性病变的预测价值 总被引:1,自引:0,他引:1
目的 通过了解绝经后妇女卵巢肿物的临床特点,探讨早期发现绝经后妇女卵巢恶性肿瘤的可行方法。方法 回顾分析302例经手术后病理证实为卵巢肿物的自然绝经后妇女的临床特点,采用B超结合血CA125的定量测定。结果 71.2%的绝经后卵巢肿物患者无自觉症状,38.7%为卵巢恶性肿瘤,BUS结合血CA125对卵巢恶性病变预测的敏感性为98.4%,特异性为57.9%,阳性预测值62.6%,阴性预测值98.1%。结论 对绝经后妇女实施妇科检查及B超的筛查结合血CA125的定量测定,有助于临床医生及时发现卵巢恶性肿瘤。 相似文献
80.
阴道超声对诊断治疗卵巢子宫内膜异位囊肿及子宫腺肌病的价值 总被引:7,自引:0,他引:7
目的探讨阴道超声及血清CA125测定对诊断治疗卵巢子宫内膜异位囊肿及子宫腺肌病的价值。方法对卵巢子宫内膜异位囊肿及子宫腺肌病患者631例进行回顾性分析,术前均经阴道超声检查,部分患者进行了血清CA125测定。结果阴道超声检查卵巢子宫内膜异位囊肿符合率98.7%;子宫腺肌病符合率91.7%;卵巢子宫内膜异位囊肿合并子宫腺肌病符合率95.1%。血清CA125检查卵巢子宫内膜异位囊肿,阳性率39.4%;子宫腺肌病阳性率52.2%;卵巢子宫内膜异位囊肿合并子宫腺肌病阳性率59.2%。结论阴道超声可做为较准确诊断卵巢子宫内膜异位囊肿及子宫腺肌病的首选方法。阴道超声下囊肿穿刺是治疗卵巢子宫内膜异位囊肿的简便、有效的方法之一。血清CA125测定可做为卵巢子宫内膜异位囊肿及子宫腺肌病的协助诊断方法,应进一步完善对照组的研究。 相似文献